Tracey L Mc Cain is EVP AND CHIEF LEGAL OFFICER of Blueprint Medicines Corp. Currently has a direct ownership of 60,498 shares of BPMC, which is worth approximately $5.85 Million. The most recent transaction as insider was on Mar 07, 2024, when has been sold 5,194 shares (Common Stock) at a price of $90.69 per share, resulting in proceeds of $471,043. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 60.5K
0% 3M change
14.87% 12M change
Total Value Held $5.85 Million

Tracey L McCain Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 07 2024
SELL
Open market or private sale
$471,043 $90.69 p/Share
5,194 Reduced 7.91%
60,498 Common Stock
Mar 01 2024
BUY
Grant, award, or other acquisition
-
12,500 Added 15.99%
65,692 Common Stock
Mar 06 2023
SELL
Open market or private sale
$149,722 $45.07 p/Share
3,322 Reduced 5.93%
52,666 Common Stock
Mar 01 2023
BUY
Grant, award, or other acquisition
-
12,500 Added 18.25%
55,988 Common Stock
Mar 07 2022
SELL
Open market or private sale
$58,831 $56.19 p/Share
1,047 Reduced 2.36%
43,227 Common Stock
Mar 03 2022
SELL
Open market or private sale
$100,487 $60.28 p/Share
1,667 Reduced 3.63%
44,274 Common Stock
Mar 01 2022
BUY
Grant, award, or other acquisition
-
12,500 Added 21.39%
45,941 Common Stock
Dec 07 2021
SELL
Open market or private sale
$482,300 $96.46 p/Share
5,000 Reduced 13.01%
33,441 Common Stock
Dec 07 2021
BUY
Exercise of conversion of derivative security
$141,800 $28.36 p/Share
5,000 Added 11.51%
38,441 Common Stock
Nov 03 2021
SELL
Open market or private sale
$550,900 $110.18 p/Share
5,000 Reduced 13.06%
33,274 Common Stock
Nov 03 2021
BUY
Exercise of conversion of derivative security
$141,800 $28.36 p/Share
5,000 Added 11.55%
38,274 Common Stock
Sep 23 2021
SELL
Open market or private sale
$2,719,500 $108.78 p/Share
25,000 Reduced 42.9%
33,274 Common Stock
Sep 23 2021
BUY
Exercise of conversion of derivative security
$709,000 $28.36 p/Share
25,000 Added 30.02%
58,274 Common Stock
Mar 04 2021
SELL
Open market or private sale
$166,224 $87.81 p/Share
1,893 Reduced 5.45%
32,852 Common Stock
Mar 01 2021
BUY
Grant, award, or other acquisition
-
13,062 Added 27.32%
34,745 Common Stock

Also insider at

KNSA
Kiniksa Pharmaceuticals, Ltd. Healthcare
IMGN
ImmunoGen, Inc. Healthcare
TLM

Tracey L Mc Cain

EVP AND CHIEF LEGAL OFFICER
Waltham, MA

Track Institutional and Insider Activities on BPMC

Follow Blueprint Medicines Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BPMC shares.

Notify only if

Insider Trading

Get notified when an Blueprint Medicines Corp insider buys or sells BPMC shares.

Notify only if

News

Receive news related to Blueprint Medicines Corp

Track Activities on BPMC